CCRM

We're pleased to share our 2025 #annualreport: Reimagining The Possible. It was a year defined by resilience, focus & forward momentum. Read about our collab w/ @IonQ_Inc, progress w/ @CCRM_au & Nordic, successes at our #GMP #CDMO & @CATTI_Training & more ccrm.ca/regenerative-m…

Very exciting publication from our lab! New drug candidate, uPAR CAR T, which targets glioblastoma at recurrence. @machealthsci @CDCR_Mac @ScienceTM Heres the story: healthsci.mcmaster.ca/new-mcmaster-m…

New blogger Sanat Khanna says advanced analytics and data literacy are the key to unlocking biomanufacturing's next frontier and #patientaccess to therapies signalsblog.ca/from-data-floo…

"Quantum is coming sooner than people think." Our Chairman and CEO @NiccoloDeMasi appeared on @CNBC with @TheDomino this morning to discuss Q1 earnings results, current quantum use cases for commercial and government clients, and our blueprint for fault tolerant quantum computing: cnb.cx/3QUKUz0

There’s a tiny Canadian-made chip powering #AI data centres, #Quantum computing and national defence. Discover how it’s driving global innovation: ow.ly/EkTe50YWhvr #NRCPhotonics

More than 70 scientists have joined UHN’s Canada Leads initiative, a global recruitment program aiming to bring 100 researchers to Canada. The initiative is designed to shape the future of research and strengthen talent for health innovation. Read more: bit.ly/4w3UkIu

Applications are open for the 2027 Peter Gilgan Canada Gairdner Momentum Award Awarded to 2 mid-career researchers in Canada, the award recognizes exceptional research with continued potential to improve human health. 📅Submit by July 15 Learn more: bit.ly/2027Momentum

@milicaruoft @TohidDidar @McMasterU @UofT Congratulations Milica!

Honored to become a Fellow of the Canadian Academy of Health Sciences yesterday in Montreal! Congrats to @TohidDidar and @Arinjay Banerjee great to see folks from my alma mater @McMasterU! Thanks @UofT @UofT for the support!

The cell and gene therapy pipeline in the United States currently features two approved products and five regulatory decision dates, with 10+ more therapies in the near-term clinical pipeline. Download ARM's Q1 2026 Sector Snapshot to learn more. alliancerm.org/resources/?_re…

Three 2026 @brkthroughprize winners reflect on developing Luxturna, a gene therapy that treats blindness caused by rare inherited eye diseases - @sciam scientificamerican.com/article/how-a-…

Researchers at @UHN and #TemertyMed have created "digital twin" lungs—computer models of human lungs—that can predict how a specific lung will behave. bit.ly/3QHf9JN

SMARTER, EARLIER, BETTER: Transforming Cancer Outcomes panel (May 26, Toronto) Leaders across research, clinical care & industry will explore how collaboration & innovation are shaping the future of cancer care in Canada. Register: lnkd.in/e8nXPA97

CCRM and #OmniaBio will be at @ISCTGlobal #ISCT2026 in Dublin this week. We’re looking forward to engaging with attendees and learning how OmniaBio can support your #CGT programs. @MichaelMay5 will be joining a panel discussion on May 8. See you there! @ThisIspoornima

Thanks to our amazing philanthropist-investors - and the Governments of Ontario & Canada- our future is routed in a science and research based economy. Science fuels prosperity and prosperity protects universal access.

After recalibrating its production strategy to better meet the realities of the CAR-T market, @GileadSciences’ @KitePharma is preparing to hit the ground running with the potential approval of a next-gen multiple myeloma cell therapy later this year fiercepharma.com/manufacturing/…

Blogger Krystal Jacques writes about new research on injured human #spinalcord organoids that is nearing #clinicaltrials. If successful, this promising new regenerative therapy could repair paralyzing injuries in humans. signalsblog.ca/new-paralysis-… @SamuelStupp @nozomu_takata @NU_CRN

CRISPR at 25: Explore the evolution and future of genome editing with Prof. Rodolphe Barrangou in our GEN Keynote Webinar, May 4, 2026. Register free: hubs.li/Q04c1Br00 @elevatebio #CRISPR #GeneTherapy

Join us tomorrow, Wednesday, April 29th at 3pm EST for a #TissueTalk from Prof. Shuichi Takayama from @GeorgiaTech @GeorgiaTechBioE on "Organoid-based reference biomodels." See you there: bit.ly/tissuetalks

With Day 1 of #CGMed26 in full swing, a new major CGT deal was just announced! ARM members Profluent and Eli Lilly announced a new strategic partnership valued at up to $2.25 billion to develop AI-designed recombinases for genetic medicines. 1/3 businesswire.com/news/home/2026…

Just released: ARM's Q1 2026 Cell & Gene Therapy Sector Snapshot! 🧬 📊 Check out this year's CGT trends, including the latest clinical pipeline, regulatory developments, commercial outlook, and company raises. Access the report here: alliancerm.org/resources/?_re…